美国 · SEC FORM 4
Alpha Cognition Inc.
ACOG · Nasdaq · CIK 0001655923 · Healthcare · Biotechnology
内部人信号
3 位买方 · 30 条买入交易行 · $5.6M 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是:TenPercentOwner(CEO、董事长和持股 10% 以上的股东得分最低)
- ✓ Recent activity · latest purchase 2026-10-01
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chief Operating Officer, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 75.2
- 75.1
- 74.9
- 74.8
- 74.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- +1.6%
- 3M
- +7.9%
- 6M
- +49.9%
- 12M
- +17.1%
波动率与流动性
- 波动率
- 74.6%
- Beta
- —
- 平均每日成交额
- USD 1.1M
估值
- 市值
- USD 196.9M
- P/E
- —
基本面
- 利润率
- -202.2%
- ROE
- -33.1%
- 细分行业
- Biotechnology
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-13 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 323,405
- 上期报告
- 209,226
- 日均成交量
- 115,854
- 回补天数
- 2.8
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 19,050 | USD 8.69 | USD 165,634 | SEC 申报 ↗ |
| 2026-09-25 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 13,426 | USD 8.47 | USD 113,718 | SEC 申报 ↗ |
| 2026-09-24 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 18,337 | USD 8.57 | USD 157,148 | SEC 申报 ↗ |
| 2026-09-16 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 80,170 | USD 8.51 | USD 682,443 | SEC 申报 ↗ |
| 2026-09-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 3,375 | USD 8.54 | USD 28,822 | SEC 申报 ↗ |
| 2026-09-14 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 40,373 | USD 8.70 | USD 351,245 | SEC 申报 ↗ |
| 2026-08-21 | Wills Robert James | 买入 (P) | Common Shares | 10,000 | USD 9.62 | USD 96,200 | SEC 申报 ↗ |
| 2026-08-03 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 50,000 | USD 8.00 | USD 400,000 | SEC 申报 ↗ |
| 2026-07-31 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 2,900 | USD 7.92 | USD 22,968 | SEC 申报 ↗ |
| 2026-07-24 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 130 | USD 7.90 | USD 1,027 | SEC 申报 ↗ |
| 2026-07-23 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 49,849 | USD 7.80 | USD 388,822 | SEC 申报 ↗ |
| 2026-07-22 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 150,237 | USD 7.83 | USD 1,176,356 | SEC 申报 ↗ |
| 2026-06-26 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 152,336 | USD 6.40 | USD 974,950 | SEC 申报 ↗ |
| 2026-06-25 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 197 | USD 6.50 | USD 1,280 | SEC 申报 ↗ |
| 2026-06-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 4,550 | USD 5.99 | USD 27,254 | SEC 申报 ↗ |
Form 4 申报证据
65 transaction lines in the latest 365-day window; 71 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 19,050 | USD 8.69 | USD 165,634 | SEC 申报 ↗ |
| 2026-09-25 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 13,426 | USD 8.47 | USD 113,718 | SEC 申报 ↗ |
| 2026-09-24 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 18,337 | USD 8.57 | USD 157,148 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 19,050 | USD 8.69 | USD 165,634 | SEC 申报 ↗ |
| 2026-09-25 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 13,426 | USD 8.47 | USD 113,718 | SEC 申报 ↗ |
| 2026-09-24 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 18,337 | USD 8.57 | USD 157,148 | SEC 申报 ↗ |
| 2026-09-16 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 80,170 | USD 8.51 | USD 682,443 | SEC 申报 ↗ |
| 2026-09-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 3,375 | USD 8.54 | USD 28,822 | SEC 申报 ↗ |
| 2026-09-14 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 40,373 | USD 8.70 | USD 351,245 | SEC 申报 ↗ |
| 2026-08-21 | Wills Robert James | 买入 (P) | Common Shares | 10,000 | USD 9.62 | USD 96,200 | SEC 申报 ↗ |
| 2026-08-03 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 50,000 | USD 8.00 | USD 400,000 | SEC 申报 ↗ |
| 2026-07-31 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 2,900 | USD 7.92 | USD 22,968 | SEC 申报 ↗ |
| 2026-07-24 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 130 | USD 7.90 | USD 1,027 | SEC 申报 ↗ |
| 2026-07-23 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 49,849 | USD 7.80 | USD 388,822 | SEC 申报 ↗ |
| 2026-07-22 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 150,237 | USD 7.83 | USD 1,176,356 | SEC 申报 ↗ |
| 2026-06-26 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 152,336 | USD 6.40 | USD 974,950 | SEC 申报 ↗ |
| 2026-06-25 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 197 | USD 6.50 | USD 1,280 | SEC 申报 ↗ |
| 2026-06-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 4,550 | USD 5.99 | USD 27,254 | SEC 申报 ↗ |
| 2026-06-12 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 273 | USD 5.93 | USD 1,619 | SEC 申报 ↗ |
| 2026-06-11 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 2,862 | USD 5.91 | USD 16,914 | SEC 申报 ↗ |
| 2026-06-10 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 5,872 | USD 5.99 | USD 35,173 | SEC 申报 ↗ |
| 2026-06-09 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 24,856 | USD 5.98 | USD 148,639 | SEC 申报 ↗ |
| 2026-06-05 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 10,054 | USD 5.83 | USD 58,615 | SEC 申报 ↗ |
| 2026-05-29 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 70,577 | USD 5.90 | USD 416,404 | SEC 申报 ↗ |
| 2026-05-28 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 2,000 | USD 5.83 | USD 11,660 | SEC 申报 ↗ |
| 2026-05-27 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 1,161 | USD 5.73 | USD 6,653 | SEC 申报 ↗ |
| 2026-05-21 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 15,945 | USD 5.70 | USD 90,886 | SEC 申报 ↗ |
| 2026-05-20 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 8,431 | USD 5.89 | USD 49,659 | SEC 申报 ↗ |
| 2026-05-19 | D'Angelo Lauren | 买入 (P) | Common Shares | 3,500 | USD 5.76 | USD 20,160 | SEC 申报 ↗ |
| 2026-05-18 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 17,395 | USD 5.69 | USD 98,978 | SEC 申报 ↗ |
| 2026-05-15 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 16,648 | USD 5.83 | USD 97,058 | SEC 申报 ↗ |
| 2026-04-16 | Sensenig Bethany | 奖励/授予 (A) | Common Shares | 5,489 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-30 | Opaleye Management Inc. | 买入 (P) | Common Stock, no par value | 1,850 | USD 4.99 | USD 9,232 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ACOG |
| CIK | 0001655923 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 71 transaction lines from 2024-11-13 to 2026-10-01 61 P purchase lines · 1 S sale lines · 9 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.